Private Capital Advisors Inc. Sells 138 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Private Capital Advisors Inc. reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 37,937 shares of the healthcare conglomerate’s stock after selling 138 shares during the period. UnitedHealth Group makes up about 2.3% of Private Capital Advisors Inc.’s investment portfolio, making the stock its 7th biggest position. Private Capital Advisors Inc.’s holdings in UnitedHealth Group were worth $19,191,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of UNH. Motive Wealth Advisors increased its stake in UnitedHealth Group by 17.1% in the fourth quarter. Motive Wealth Advisors now owns 755 shares of the healthcare conglomerate’s stock valued at $382,000 after purchasing an additional 110 shares in the last quarter. MFA Wealth Services bought a new stake in UnitedHealth Group in the fourth quarter valued at approximately $512,000. Financial Partners Group LLC increased its stake in UnitedHealth Group by 0.5% in the fourth quarter. Financial Partners Group LLC now owns 8,055 shares of the healthcare conglomerate’s stock valued at $4,074,000 after purchasing an additional 42 shares in the last quarter. Greater Midwest Financial Group LLC increased its position in shares of UnitedHealth Group by 7.7% during the fourth quarter. Greater Midwest Financial Group LLC now owns 4,897 shares of the healthcare conglomerate’s stock worth $2,477,000 after acquiring an additional 351 shares in the last quarter. Finally, Brighton Jones LLC increased its position in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after acquiring an additional 28,231 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 0.5 %

UnitedHealth Group stock opened at $532.26 on Friday. The company has a market capitalization of $489.83 billion, a PE ratio of 34.34, a PEG ratio of 1.41 and a beta of 0.62. The firm’s fifty day moving average is $542.24 and its 200 day moving average is $563.54. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $5.83 EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.74 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.58%. UnitedHealth Group’s payout ratio is 54.19%.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on UNH shares. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday. Royal Bank of Canada decreased their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Barclays decreased their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Bank of America decreased their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Finally, HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price for the company in a research note on Friday, January 10th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Buy” and a consensus price target of $627.74.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.